Analysis of apoptosome dysregulation in pancreatic cancer and of its role in chemoresistance

Cancer Biology and Therapy

Volumn 6, Issue 2, 2007, Pages 209-217

  Corvaro, Marco ^a   Fuoco, Claudia ^a,b   Wagner, Martin ^c   Cecconi, Francesco ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

Apaf1; Apoptosis; Caspase(s); Chemosensitivity; Pancreatic adenocarcinoma

Indexed keywords

APOPTOSOME; APOPTOTIC PROTEASE ACTIVATING FACTOR 1;

AMINO ACID SEQUENCE; ARTICLE; CELL DEATH; CONTROLLED STUDY; EPIGENETICS; HUMAN; HUMAN CELL; PANCREAS CANCER; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 34247344500     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.6.2.3622     Document Type: Article

References (34)

1. Boatright KM, Salvesen GS. Mechanisms of caspase activation. Curr Opin Cell Biol 2003; 15:725-31.
2. Hill MM, Adrain C, Martin SJ. Portrait of a killer: The mitochondrial apoptosome emerges from the shadows. Mol Interv 2003; 3:19-26.
3. Jiang X, Wang X. Cytochrome C-mediated apoptosis. Annu Rev Biochem 2004; 73:87-106.
4. Haupt S, Berger M, Goldberg Z, Haupt Y. Apoptosis - The p53 network. J Cell Sci 2003; 116:4077-85.
5. Nakamura Y. Isolation of p53-target genes and their functional analysis. Cancer Sci 2004; 95:7-11.
6. Soengas MS, Alarcon RM, Yoshida H, Giaccia AJ, Hakem R, Mak TW, Lowe SW. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 1999; 284:156-9.
7. Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordon-Cardo C, Lowe SW. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 2001; 409:207-11.
8. Soengas MS, Lowe SW. Apoptosis and melanoma chemoresistance. Oncogene 2003; 22:3138-51.
9. Baldi A, Santini D, Russo P, Catricala C, Amantea A, Picardo M, Tatangelo F, Botti G, Dragonetti E, Murace R, Tonini G, Natali PG, Baldi F, Paggi MG. Analysis of APAF-1 expression in human cutaneous melanoma progression. Exp Dermatol 2004; 13:93-7.
10. Shinoura N, Sakurai S, Asai A, Kirino T, Hamada H. Transduction of Apaf-1 or caspase-9 induces apoptosis in A-172 cells that are resistant to p53-mediated apoptosis. Biochem Biophys Res Commun 2000; 272:667-73.
11. Watanabe T, Hirota Y, Arakawa Y, Fujisawa H, Tachibana O, Hasegawa M, Yamashita J, Hayashi Y. Frequent LOH at chromosome 12q22-23 and Apaf-1 inactivation in glioblastoma. Brain Pathol 2003; 13:431-9.
12. Yamamoto H, Gil J, Schwartz Jr S, Perucho M. Frameshift mutations in Fas, Apaf-1, and Bcl-10 in gastro-intestinal cancer of the microsatellite mutator phenotype. Cell Death Differ 2000; 7:238-9.
13. Bala S, Oliver H, Renault B, Montgomery K, Dutta S, Rao P, Houldsworth J, Kucherlapati R, Wang X, Chaganti RS, Murty VV. Genetic analysis of the APAF1 gene in male germ cell tumors. Genes Chromosomes Cancer 2000; 28:258-68.
14. Sturm I, Bosanquet AG, Radetzki S, Hummel M, Dorken B, Daniel PT. Silencing of APAF-1 in B-CLL results in poor prognosis in the case of concomitant p53 mutation. Int J Cancer 2006; 118:2329-36.
15. Cowgill SM, Muscarella P. The genetics of pancreatic cancer. Am J Surg 2003; 186:279-86.
16. Hilgers W, Kern SE. Molecular genetic basis of pancreatic adenocarcinoma. Genes Chromosomes Cancer 1999; 26:1-12.
17. Hahn SA, Seymour AB, Hoque AT, Schutte M, da Costa LT, Redston MS, Caldas C, Weinstein CL, Fischer A, Yeo CJ, et al. Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res 1995; 55:4670-5.
18. Kimura M, Abe T, Sunamura M, Matsuno S, Horii A. Detailed deletion mapping on chromosome arm 12q in human pancreatic adenocarcinoma: Identification of a I-cM region of common allelic loss. Genes Chromosomes Cancer 1996; 17:88-93.
19. Kimura M, Furukawa T, Abe T, Yatsuoka T, Youssef EM, Yokoyama T, Ouyang H, Ohnishi Y, Sunamura M, Kobari M, Matsuno S, Horii A. Identification of two common regions of allelic loss in chromosome arm 12q in human pancreatic cancer. Cancer Res 1998; 58:2456-60.
20. Seymour AB, Hruban RH, Redston M, Caldas C, Powell SM, Kinzler KW, Yeo CJ, Kern SE. Allelotype of pancreatic adenocarcinoma. Cancer Res 1994; 54:2761-4.
21. Wagner M, Greten FR, Weber CK, Koschnick S, Mattfeldt T, Deppert W, Kern H, Adler G, Schmid RM. A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes Dev 2001; 15:286-93.
22. Moore PS, Sipos B, Orlandini S, Sorio C, Real FX, Lemoine NR, Gress T, Bassi C, Kloppel G, Kalthoff H, Ungefroren H, Lohr M, Scarpa A. Genetic profile of 22 pancreatic carcinoma cell lines: Analysis of K-ras, p53, p16 and DPC4/Smad4. Virchows Arch 2001; 439:798-802.
23. Sipos B, Moser S, Kalthoff H, Torok V, Lohr M, Kloppel G. A comprehensive characterization of pancreatic ductal carcinoma cell lines: Towards the establishment of an in vitro research platform. Virchows Arch 2003; 442:444-52.
24. Allen JD, Zhang XD, Scott CL, Boyle GM, Hersey P, Strasser A. Is Apaf-1 expression frequently abrogated in melanoma? Cell Death Differ 2005; 12:680-1.
25. Peltenburg LT, de Bruin EC, Meersma D, Smit NP, Schrier PI, Medema JP. Expression and function of the apoptosis effector Apaf-1 in melanoma. Cell Death Differ 2005; 12:678-9.
26. Soengas MS, Gerald WL, Cordon-Cardo C, Lazebnik Y, Lowe SW. Apaf-1 expression in malignant melanoma. Cell Death Differ 2006; 13:352-3.
27. Salvesen GS, Dixit VM. Caspase activation: The induced-proximity model. Proc Natl Acad Sci USA 1999; 96:10964-7.
28. Debatin KM, Krammer PH. Death receptors in chemotherapy and cancer. Oncogene 2004; 23:2950-66.
29. Hajra KM, Liu JR. Apoptosome dysfunction in human cancer. Apoptosis 2004; 9:691-704.
30. Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: A link between cancer genetics and chemotherapy. Cell 2002; 108:153-64.
31. Scott CL, Schuler M, Marsden VS, Egle A, Pellegrini M, Nesic D, Gerondakis S, Nutt SL, Green DR, Strasser A. Apaf-1 and caspase-9 do not act as tumor suppressors in myc-induced lymphomagenesis or mouse embryo fibroblast transformation. J Cell Biol 2004; 164:89-96.
32. Gerhard MC, Schmid RM, Hacker G. Analysis of the cytochrome c-dependent apoptosis apparatus in cells from human pancreatic carcinoma. Br J Cancer 2002; 86:893-8.
33. Herbst RS, Khuri FR. Mode of action of docetaxel - A basis for combination with novel anticancer agents. Cancer Treat Rev 2003; 29:407-15.
34. Faleiro L, Kobayashi R, Fearnhead H, Lazebnik Y. Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells. Embo J 1997; 16:2271-81.